Besides, the formation of the MLL-AF9 fusion gene has been associated with acute myelogenous leukaemia (AML), acute lymphoblastic leukaemia (ALL), myelodysplastic syndromes (MDS) and therapy-related AML (t-AML) [89, 108]. This evidence concerns the gene MLLT3 and myelodysplastic syndrome.